Home' Australian Pharmacist : December 2011 Contents Vol. 30 -- December #12, 2011
A new model
for a new era
PSA has recognised for quite some
time that the business model based
on dispensing and direct supply that
has served community pharmacy
well for the past 50 years, is now in
decline, according to the PSA
The Clinical and Practice Expo
(CPExpo), being held 25--27 May 2012
at the Hordern Pavillion in Sydney, is
recognition of this need for change.
PSA initiated the Future of Pharmacy
project involving all branches of the
profession two years ago.
PSA NSW Branch
Drew said CPExpo
was unique as it
was designed to
patients, allied health professionals
and the pharmaceutical industry with
the aim of improving Australia's health
through excellence in the practice of
'PSA is the leading pharmacy
professional organisation, renowned for
its high-quality clinical, practice-based
education practice improvement
programs that nurture and grow the
pharmacy profession's capacity and
" Mr Drew said.
NSW Branch Committee member,
Warwick Plunkett said that it seemed
obvious that the future business
model for community pharmacy must
be built around pharmacist-delivered
professional services -- services which
will improve or optimise patient health
PSA appreciates the enormous
cultural shift that will be required
within current pharmacist practice to
facilitate the success of such a model.
This has led to the realisation that
a change must occur in the way it
delivers education to pharmacists.
Mr Plunkett said that change to a more
practice-oriented and patient outcome
focus was embodied in the format of
the new Clinical and Practice Expo.
CPExpo aims to attract sponsors and
exhibitors from the pharmaceutical
industry and patient support groups
to be an integral part of the event.
They are encouraged to be proactive
with delegates, providing them
with not only product information,
but details materials they produce
for pharmacists, GPs and patients.
In this way it is hoped sponsors
and exhibitors will become active
participants in the pharmacist's
learning experience from the Expo.
Innovative ways of doing this are
encouraged. About 40% of the
Expo time is devoted to interaction
between exhibitors and delegates.
This time can be used by running
mini workshops led by the sponsors
and exhibitors' own experts.
Exhibitors may want to bring in
patients using their products
to discuss issues they need
pharmacists to assist them with.
It is hoped that the Clinical and
Practice Expo will prove to be the
best vehicle to facilitate that.
Mr Drew said, 'CPExpo is destined
to become another PSA must-attend
event for the pharmacy profession.
This new-look event focusses on
the quality use of medicines and
therapeutic updates as well as
clinical and professional services.
He said the winning formula
of innovation, education and
networking along with the
exciting initiative of promoting and
supporting patients and patient
support group collaboration
promises to be a big drawcard.
'By pursuing an innovative
collaboration between industry,
patient support groups and health
professionals, CPExpo provides a
unique promotional opportunity to
present the clinical and practical
aspects of your products and
' Mr Drew said.
'Replacing the outdated "trade"
show model, this new format
provides pharmaceutical companies
with myriad options to interact with
a key stakeholders, integral to the
provision of medicines information
and medication management.
Mr Drew said busy but nonetheless
committed pharmacists wanting
to maximise learning outcomes
relevant to their practice would
relish the chance to keep up-to-date
with their clinical knowledge, new
product information and health
initiatives in a single event.
Asthma rates drop
The prevalence of asthma among
children and young adults has
decreased in the past decade,
according to a new Australian Institute
of Health and Welfare (AIHW) report.
The report, Asthma in Australia 2011,
was launched last month by Professor
Guy Marks, Director of the Australian
Centre for Asthma Monitoring (ACAM)
at the Woolcock Institute of Medical
Research in Sydney.
'Between 2001 and 2007--08, the
prevalence of asthma declined in
people aged five to 34 years by over
one quarter, but remained stable
in adults aged 35 years and over,
Professor Marks said.
The report also shows a decrease
in deaths from asthma, with the
mortality rate due to asthma dropping
by 45% between 1997 and 2009.
'Despite these improvements,
asthma prevalence and mortality
rates in Australia remain high on an
' Professor Marks
In 2007--08, the prevalence of asthma
in Australia was estimated to be
about one in ten -- equivalent to about
2 million people.
'People with asthma also smoke
at least as much as people without
asthma, despite the known adverse
' Professor Marks said.
Rates of hospitalisation for asthma
among adults are higher in Indigenous
people compared with other
Australians. Also, people living in
areas of lower socioeconomic status
are more likely to be hospitalised for
asthma than those living in areas of
higher socioeconomic status and this
gap has widened in recent years.
The report includes a focus chapter
on chronic obstructive pulmonary
disease (COPD) -- a serious long-term
lung disease that mainly affects
older people and is often difficult to
distinguish from asthma. In Australia,
smoking is the main cause of COPD.
Among people aged 55 years and
over, deaths and hospitalisations are
much more commonly caused by
COPD than by asthma.
'The good news is that between 1997
and 2007, the death rate attributed
to COPD among people aged 55
years and over decreased by 65%,
Professor Marks said.
Links Archive Australian Pharmacist January 2012 November 2011 Navigation Previous Page Next Page